06 — Market
A €4.5B opportunity hiding in plain sight.
Three converging clinical workflows — ablation prioritisation, stroke care and NOAC decisions — define a meaningful addressable market for an integrated, CT-native solution.
Ablation priority
€1.0B
Stroke care
€1.5B
NOAC decision
€2.0B
TAM
€0.0B
Total addressable
SAM
€0.0B
Serviceable
SOM
€0M
5-year obtainable
05 — Traction
Momentum across capital, clinic and channel.
Backed by leading Nordic investors, anchored at Linköping University, and progressing toward integrated distribution through the imaging platforms clinicians already use.
Patent filed
PCT 2025
LOI
Sectra AB
TRL
4 – 5
Studies
Active with clinics
KOL
Discussions ongoing
Seed
€650k
Roadmap
2024
Founded
Spin-out from Linköping University
2025
Patent filed
PCT/EP2025/088821
2025
Seed round
€650k — Almi Invest, East Sweden Capital
2026
Pre-Series A
Pilot deployments & MDR 2A path
2027
Primary AF product
MDR 2A clearance
2029
FDA
Primary AF product · NAM expansion
Cordicity
More than improved imaging.
Talk to the team building the next quantitative marker in stroke care — whether you are a clinician, a partner, an investor or a future colleague.